Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 05, 2021

SELL
$180.55 - $233.54 $5.56 Million - $7.19 Million
-30,805 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $212,794 - $275,472
-1,295 Reduced 4.03%
30,805 $5.76 Million
Q4 2020

Feb 16, 2021

SELL
$130.46 - $172.63 $189,558 - $250,831
-1,453 Reduced 4.33%
32,100 $5.42 Million
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $87,732 - $101,478
-600 Reduced 1.76%
33,553 $4.96 Million
Q2 2020

Aug 14, 2020

SELL
$136.42 - $164.18 $599,020 - $720,914
-4,391 Reduced 11.39%
34,153 $5.6 Million
Q1 2020

May 14, 2020

SELL
$119.05 - $147.35 $1.65 Million - $2.04 Million
-13,829 Reduced 26.4%
38,544 $5.34 Million
Q2 2019

Sep 11, 2019

BUY
$110.79 - $129.32 $5.77 Million - $6.74 Million
52,081 Added 17835.96%
52,373 $0
Q2 2019

Aug 27, 2019

SELL
$110.79 - $129.32 $7.29 Million - $8.51 Million
-65,841 Reduced 99.56%
292 $32,000
Q1 2019

May 10, 2019

SELL
$111.31 - $131.02 $3.57 Million - $4.2 Million
-32,080 Reduced 32.66%
66,133 $8.58 Million
Q4 2018

Feb 15, 2019

BUY
$105.9 - $118.64 $1.9 Million - $2.12 Million
17,910 Added 22.3%
98,213 $11.4 Million
Q2 2018

Aug 06, 2018

BUY
$75.7 - $86.88 $144,057 - $165,332
1,903 Added 2.43%
80,303 $0
Q1 2018

May 11, 2018

SELL
$74.21 - $87.6 $549,154 - $648,240
-7,400 Reduced 8.62%
78,400 $0
Q4 2017

Feb 07, 2018

BUY
$81.94 - $87.89 $1.58 Million - $1.7 Million
19,300 Added 29.02%
85,800 $7.25 Million
Q3 2017

Oct 23, 2017

BUY
$77.07 - $85.54 $5.13 Million - $5.69 Million
66,500
66,500 $5.69 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track River & Mercantile Asset Management LLP Portfolio

Follow River & Mercantile Asset Management LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River & Mercantile Asset Management LLP, based on Form 13F filings with the SEC.

News

Stay updated on River & Mercantile Asset Management LLP with notifications on news.